Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
1 Parkinson’s Drug Can Hinder the Gold-Standard Treatment
Researchers at Yale School of Medicine discovered that catechol‑O‑methyltransferase inhibitors (COMT‑Is), commonly added to levodopa therapy for Parkinson's disease, can unintentionally reshape the gut microbiome. The altered microbiome favors growth of Enterococcus faecalis, a bacterium that metabolizes levodopa before it reaches the brain, reducing the drug's effectiveness. The study, published in Nature Microbiology, underscores a non‑hepatic drug‑drug interaction mediated by gut microbes. These findings suggest clinicians may need to reconsider co‑prescribing practices for Parkinson's patients.
RFK Jr. Says China Is 'Eating Our Lunch' In Biotech Advances
HHS Secretary Robert F. Kennedy Jr. warned Congress that China is outpacing the United States in biotech, citing faster new‑drug approvals and a surge in clinical‑trial starts. He highlighted that China approved more than 70 novel therapies in 2025, compared with roughly 45...
Dangers Coming From Inside the House
John D. Spengler, a pioneer in indoor air quality research, reflects on five decades of work that reshaped public health policies—from smoking bans on airplanes to reducing asthma triggers in public housing. His early findings from the 1970s Six Cities...
From Dashboards to Decision‑Making: Voice‑Chat Analytics
The next enterprise advantage will not come from more dashboards. It will come from systems that let executives ask: What changed? Why does it matter? What are my options? What could make this wrong? I’ve wanted to build that for...
CMS’ Chris Klomp, Stephanie Carlton Talk Affordability, Prior Authorization, Drug Pricing
CMS Deputy Administrator Chris Klomp and Chief of Staff Stephanie Carlton outlined the agency’s recent policy agenda, emphasizing four pillars—fraud reduction, affordability, health‑initiative programs, and AI‑driven streamlining. They highlighted a voluntary agreement to overhaul prior‑authorization processes and a 2025 most‑favored‑nation drug‑pricing pledge...
The Military Just Made Flu Shots Optional. Here’s Why That’s Controversial
Defense Secretary Pete Hegseth announced that flu vaccinations will no longer be mandatory for active, reserve, and civilian Department of Defense personnel, making the shots voluntary. The policy reverses a mandate that has existed since World War II, citing concerns over...
Rep. Blake Moore Discusses Health Care Affordability
Rep. Blake Moore, vice chair of the House Republican Conference and Ways and Means health subcommittee member, held a fireside chat with Sanford Health CEO Bill Gassen to address health‑care affordability. Moore outlined his House Budget Committee Health Care Task...
Merck's Welireg Combo Fails in First-Line Kidney Cancer
Merck reported that adding Welireg (lenvatinib) to Keytruda (pembrolizumab) did not improve outcomes for treatment‑naïve patients with advanced renal cell carcinoma. In the phase‑3 CLEAR trial, the combination failed to meet its primary progression‑free survival endpoint, showing a median of...
Childhood Adversity Predicts Combined Physical and Mental Illness in Later Life
Researchers analyzing data from over 4,000 Chinese adults aged 45 and older found that cumulative childhood adversity markedly increases the likelihood of developing both depression and chronic physical disease later in life. Participants reporting four or more adverse childhood experiences...
Jeremy Renner Backs RapidSOS Emergency Platform to Advance AI
Actor Jeremy Renner has invested in and partnered with emergency‑response platform RapidSOS, aiming to accelerate AI‑driven data sharing for first responders. RapidSOS pulls real‑time health, location and sensor data from smartphones, wearables, vehicles and surveillance to deliver richer information before...
Healthcare Must Stop Normalizing Disordered Eating and Privilege
It’s my birthday today and I wish for all healthcare providers to learn about the ways we normalize disordered eating on a daily basis. We need to recognize atypical anorexia and stop encouraging restriction under the guise of health. We...
Merck’s Fast-Ascending Kidney Cancer Drug Hits a Setback
Merck announced that Welireg, combined with Keytruda and Lenvima, failed to meet primary endpoints in a Phase 3 first‑line clear‑cell renal cell carcinoma trial, missing both progression‑free and overall survival benefits. The setback curtails Merck’s plan to use Welireg to offset...
How Commercial Insurers, Self-Insured Employers, PBMs, and Manufacturers Are Turning GLP-1 Pharmacy Benefits Into Active Managed-Access Operating Systems and Where...
Commercial insurers, self‑insured employers and PBMs are overhauling GLP‑1 pharmacy benefits as the class erupts in cost and utilization. KFF data shows 43% of firms with 5,000+ employees now cover GLP‑1s for weight loss, up from 28% a year earlier,...
Strategic Insights: The Last King of Babylon
Babylon Health, founded by Iranian‑born entrepreneur Ali Parsa in 2013, rode a wave of AI‑driven telemedicine hype to a 2021 IPO that valued the company at $4.2 billion. Within two years, mounting regulatory scrutiny, clinician distrust and operational shortfalls forced the...
UnitedHealth Breaks Down How It Plans to Spend $1.5B on AI
UnitedHealth Group confirmed it is on track to invest $1.5 billion in artificial intelligence this year. The spend will fund internal efficiency projects and the development of AI‑driven solutions for other insurers and health providers. UnitedHealth aims to embed generative AI...
Better Healthcare Delivered—In SE Alaska It’s All in Black and White
Southeast Alaska Regional Health Consortium (SEARHC) partnered with advertising firm R&R Partners to launch a new campaign that features real SEARHC providers speaking about care delivery. The campaign relies on authentic, black‑and‑white photography to convey the seriousness of healthcare in...
Navigating with Excellence: The Multi-Faceted Service Lines of Precision Logistics
Marken UPS Healthcare Precision Logistics has unveiled an eBook detailing its seven specialized service lines that support the pharmaceutical supply chain from manufacture to bedside. The firm emphasizes cold‑chain innovation, real‑time visibility, and rigorous regulatory compliance to safeguard high‑value, temperature‑sensitive...
What Does It Take to Scale Cell and Gene Therapies From Discovery to Commercialization
MaxCyte CEO Maher Masoud says scaling cell and gene therapies requires developers to partner with manufacturers that can move seamlessly from R&D to commercial production. Integrated, best‑in‑class platforms eliminate the need for repeated process re‑optimization, enabling consistent, automated manufacturing. Advances...
Do You Risk Stratify Your Patients for Post-Op Opioid Persistence?
A Finnish nationwide registry linked ACDF surgeries to pharmacy records, revealing that 41.9% of patients filled opioid prescriptions and 41.2% filled gabapentinoids before surgery. Post‑operatively, 69.5% of pre‑op opioid users and 70.9% of gabapentinoid users stopped purchasing these drugs, and...
FDA Public Meeting on Increasing Access to Nonprescription Drugs - 04/23/2026
The FDA announced a public meeting on April 23, 2026 to discuss expanding access to nonprescription, or over‑the‑counter (OTC), drugs. The agency is soliciting comments through May 8, 2026, with an earlier deadline of Feb 2, 2026 to shape the agenda. Topics include identifying conditions that...
Physician-Owned Hospitals Get a Narrow CMS Opening
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (CMS‑1849‑P) asking whether its Innovation Center can waive the ACA’s Section 6001 to let physician‑owned hospitals voluntarily join the Transforming Episode Accountability Model. A 2023 study found these...
Acorys System Gains FDA Clearance for Real-Time 4D Cardiac Mapping
Corify Care’s Acorys system received FDA clearance, offering clinicians a real‑time, four‑chamber view of cardiac electrical activity without the need for CT or MRI scans. The platform merges 3D anatomical modeling with live electrical signals, creating what the company calls...
FDA Accepts BLA for Gazyva/Gazyvaro for Systemic Lupus Erythematosus
Roche has received FDA acceptance of its supplemental Biologics License Application for obinutuzumab (Gazyva/Gazyvaro) as a treatment for systemic lupus erythematosus, with a regulatory decision expected by December 2026. The approval request is backed by the Phase III ALLEGORY trial, which...
Pharmacy System Saves Texas Children's Hospital $14M, and That's Just for Starters
Texas Children’s Hospital replaced its manual pharmacy inventory process with an RFID‑enabled Tecsys point‑of‑use platform, focusing on high‑cost medications. Partnering with Zebra Technologies, the hospital equipped refrigerators and cabinets with RFID tags and handheld scanners, delivering real‑time visibility of stock,...
GMEX Robotics Advances Autonomous Hospital Logistics Platform to Enhance Safety, Efficiency and Operational Workflow
GMEX Robotics announced an upgraded autonomous Hospital Logistics Robot designed to improve durability, ergonomics and safety in high‑traffic medical settings. The new chassis resists impacts while the delivery height is optimized to prevent staff from bending to retrieve supplies. Integrated...
UnitedHealth Q1 '26 Earnings: Wall Street Is in Love Again
UnitedHealth Group posted Q1 2026 revenue of $111.7 billion and adjusted earnings per share of $7.23, beating the $6.57 consensus by 11%. The company raised its full‑year adjusted EPS guidance to over $18.25 per share and saw its stock jump about 9%...
NHS Couch to 5K Logs 1 Billion Minutes and 8 Million Downloads, Fueling UK Fitness Surge
The NHS Couch to 5K program announced it has crossed the 1 billion‑minute mark and amassed 8 million app downloads, a decade‑long public‑health milestone. The surge is reshaping community running, straining primary‑care sports‑medicine services and generating new economic activity in local sports...
Proximie and NVIDIA Team Up to Power AI‑Driven Operating Rooms
Proximie has announced a partnership with NVIDIA to embed the chipmaker’s foundation‑model platform into its Smart OR system. The collaboration, part of NVIDIA’s Project Rheo, aims to boost operating‑room productivity by as much as 24% and add up to 300...
Building a Stable Physician Workforce: Insights From Healthcare Executives
Hospital and health system leaders convened at Becker’s 16th Annual Meeting to address physician shortages and workforce instability. Executives from Salem Health, Asante, Endeavor Health, and Corewell Health shared models that blend locum tenens, care‑team structures, and robust change‑management tactics....
Larkin University to Open $110,000‑Sq‑Ft Osteopathic School in South Miami‑Dade by 2028
Larkin University announced plans to open the Jacqueline Nicole Michel College of Osteopathic Medicine on a 48‑acre South Miami‑Dade site in fall 2028. The 110,000‑square‑foot campus targets Florida’s looming shortage of nearly 18,000 doctors by 2035 and promises to create jobs while...
Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval - 05/09/2024
On May 9, 2024, the FDA’s Office of Generic Drugs hosted a webinar on the redesigned pre‑submission meetings under GDUFA III. The session outlined new scope, procedural updates, and illustrated a hypothetical case to help sponsors prepare effective meeting requests. Speakers...
How to Prevent the Most Common Complication After Heart Surgery
Postoperative atrial fibrillation (POAF) remains the most frequent complication after cardiac surgery, affecting up to 50% of combined CABG‑valve cases and 20‑40% of isolated procedures. The Society of Thoracic Surgeons (STS) released a 15‑point clinical practice guideline, offering eight preventive,...
AI Can Streamline Drug Approval, Boost Biotech Valuations
That is an interesting idea. This doesn't seem catered to investors per se, but with two partners in the summer of 25, we explored building an “AI-powered AlphaSense for biopharma” ultimately concluding it was too much work to do as...
Complex Generics News
The FDA’s Center for Drug Evaluation and Research is intensifying its focus on complex generic drugs, which feature intricate active ingredients, formulations, or delivery systems. Recent milestones include the July 2023 approval of the first generic Vivitrol injectable and the March 2026...
Genflow and Acuitas Forge Fully Funded LNP Collaboration to Accelerate SIRT6 Gene Therapies
Genflow Biosciences announced a strategic, fully funded collaboration with Acuitas Therapeutics to apply Acuitas' lipid‑nanoparticle (LNP) delivery platform to Genflow's SIRT6 mRNA payload. The non‑dilutive agreement lets Genflow generate preclinical data without cash outlay, signaling strong external validation of its...
From Dorm to $275M: Early Ovarian Cancer Detection Breakthrough
This is my friend Surbhi Sarna. She came to Draper University in 2012. She had painful ovarian cysts as a teenager, but doctors didn’t have tools that could detect cancer without harming the ovaries. She studied molecular biology at UC Berkeley. Then came...
Healthcare Leaders Can Pursue Innovation Without Stagnation
Healthcare leaders aren’t choosing between innovation and standing still. Jason Considine lays out the reality many providers are navigating. 👇 🔗https://t.co/oHa2I30o19 @ynhhealth @Experian #RCM #digitalhealth https://t.co/RDA5wMYyRW
Daraxonrasib Beats Chemo in Pre‑treated Metastatic Pancreatic Cancer
#ASCO26 LBA5 - Wolpin - Daraxonrasib RAS(ON) multi-selective inhibitor vs chemo in prior Tx metastatic pancreatic adenocarcinoma (mPDAC) - Ph3 RASolute 302 [May 31, 2026] https://t.co/oWEeVo2oyq #NCT06625320 #pancsm #caxtx #PrecisionMedicine https://t.co/adz922fg5z
Ivonescimab Plus Chemo Rivals Tislelizumab in First‑line sqNSCLC
#ASCO26 LBA4 - Zhiwei - Ivonescimab + chemo vs tislelizumab + chemo 1L sq NSCLC - Ph3 HARMONi-6 [May 31, 2026] Zhiwei et al. https://t.co/oWEeVo2oyq #NCT05840016 #lcsm #ImmunoOnc https://t.co/NP2qr2gPuY
Adjuvant Selpercatinib Shows Promise
#ASCO26 LBA3 - Goldman - EFS w/ adjuvant sepercatinib in stage IB-IIIA RET fusion-positive NSCLC: Ph3 LIRETTO-432 trial https://t.co/oWEeVo2oyq #NCT04819100 #lcsm #PrecisionMedicine https://t.co/HWIS9mg57w
Phase 3 Trial Shows Abemaciclib Benefits Advanced Liposarcoma
#ASCO26 LBA2 - Dickson -SARC041: Ph3 DBRCT abemaciclib vs placebo in Pts w/ adv dedifferentiated liposarcoma [May 31, 2026] https://t.co/oWEeVo2oyq #NCT04967521 #scmsm https://t.co/uD6A9JmBCn
Pharma Leaders Leverage Twitter For
A healthcare case study of @ASCO, @Novartis & @Boehringer conversation on twitter [Jan 22, 2015] via @whydotpharma (now @SiljaChouquet ) https://t.co/6xeCaqs8GO #socpharm
Perioperative
#ASCO26 LBA1 - Taplin - Perioperative APA + ADT - prostate CA [May 31, 2026] https://t.co/oWEeVo2oyq #NCT03767244 #pcsm https://t.co/8o91ntAwL9
Two Decades of Evolving ASCO Clinical Trial Trends
Trends and characteristics of clinical trials presented in ASCO plenary sessions (2011–2025) [] Overheu #ASCO26 Abstract # 11024, Poster Bd # 7 https://t.co/JYI0LY7FbU #ClinicalTrials #ctsm @ASCO
Labor Dept Demands PBM Payment Transparency Amid Legal Pushback
The Labor Department wants pharmacy benefit managers to disclose, for the first time, all the different ways they get paid. PBMs are warning this proposal is illegal. Supporters want the proposal to go further. The black box of Rx prices...
Doctor’s Insider Tips to Ease NAD IV Experience
Feel “weird” during an NAD IV? Here are the insider tips from a top doctor, @joseph_purita, to make things smoother:
Scientists Save Billions; CRISPR Cures Sickle Cell
You live in luxury. Without scientists, 6 billion of us would not be alive & the rest would live in hell. Remember that Great choices @brkthroughprize 🏆 Congrats to my colleague @Harvard, Stu Orkin, who won the prize for helping cure...
First Trial Shows Best‑in‑Class NLRP3 Inhibitor Promise
Excited to complete our first clinical trial for BGE-102. Clinical data supporting best-in-class potential, built on new chemistry and a novel binding site targeting NLRP3 - a central driver of of chronic inflammation in aging. On to Phase 2!
Cancer Patients Evolve Into Expert Co‑Navigators
The Rise of the Expert Patient in Cancer: From Backseat Passenger to Co-navigator [Mar 28, 2022] @AndreaAnampaG @JFreemanDaily et al. @DrSGraff @JCOOP_ASCO https://t.co/PO5mhwZ8hh #COSMonc @COSMOCollab https://t.co/zsKBvUprIE
Zero‑Cost AI Agents Will Redefine Radiology by 2026
AI agents near zero cost. Direct patient access to imaging. New roles in follow-up care. This panel with @PocketHealthHQ laid out what will quietly transform radiology in the next 2 years. 👇 https://t.co/GTRAx2un8A #Imaging #PatientExperience